Bridget Breslin

Bridget Breslin has extensive experience in regulatory affairs, currently serving in this capacity at PAI Pharma since February 2023. Prior roles include Associate Director at Merck from January 2018 to October 2021 and Sr. Manager, Manager, and various specialist roles at Teva Pharmaceuticals between May 2008 and January 2018. Earlier experience includes a position in regulatory affairs at Colorcon from April 2006 to May 2008 and a role as an analytical and R&D chemist at Occidental Chemical Corp. from 1990 to 1998. Educational qualifications include a Bachelor of Science in Chemistry from Carnegie Mellon University and a certificate in Drug Development with a focus on Quality Assurance/Regulatory Affairs from Temple University.